Permanent hearing loss with iopamidol following aortic angiography in a hemodialysis patient: a case report and review of the literature.
Nonionic low-osmolar contrast agents are considered safe for intravenous or intra-arterial administration and are used widely in the general population, as well as in patients on hemodialysis therapy. There are data limited to case reports for contrast-induced hearing loss; however, the ototoxicity induced by contrast agents in patients with chronic kidney disease has never been described. We report a case of permanent sensorineural deafness after abdominal aortic angiography with iopamidol in a woman with end-stage renal disease on hemodialysis therapy and review the literature relating to contrast use with the development of hearing impairment.
Karim
Mohammed R
MR
Nassau University Medical Center, East Meadow, NY 11554, USA.
Balsam
Leah
L
Rubinstein
Sofia
S
D000792:Angiography; D001012:Aorta, Abdominal / Q000000981:diagnostic imaging; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D007479:Iopamidol / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D006435:Renal Dialysis
D003287:Contrast Media; D007479:Iopamidol